Event Type: Webinar organized by IIFL Capital for investor/analyst interaction regarding the company's business transformation journey
Date and Time: September 29, 2026 (Tuesday) at 4:30 PM IST (12 noon BST, 7:00 AM ET, 7:00 PM HKT)
Purpose: To discuss the company's comprehensive transformation journey and key growth engines including controlled substances, complex formulations & injectables, oncology, first-to-file/Para IV opportunities, and peptide CDMO
Management Participants: The webinar will feature Granules' promoter and senior management team, though specific designations are not provided in the disclosure
Materials Availability: The disclosure mentions that webinar details and registration link are enclosed with the letter, but does not specify if presentation decks or recordings will be made available
Compliance Statement: The intimation is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Financial and Strategic Context
The company highlights that formulations now account for approximately 75% of revenue
There has been a sharp reduction in dependence on the legacy-5 portfolio from approximately 85% in FY23 to less than 50% in FY26
Key discussion topics will include sustainability in controlled substances markets with DEA quotas and compliance requirements
Roadmap for complex products including potential injectables and their impact on portfolio and margins
Monetization strategies for oncology gross block, product pipeline, and potential 180-day exclusivity opportunities from FY28
Size and quality of first-to-file/Para IV pipeline
Peptide CDMO platform development through Senn with opportunities across peptides/oligos/ADCs targeting USD 100 million revenue opportunity over next 4-5 years
How the evolving business mix will translate into revenue growth and margin expansion over the next 3-5 years
Additional Notes
The disclosure includes an attachment with webinar details and registration link (https://www.iiflcap.com/webinar)
No specific financial data or performance metrics were disclosed in this announcement beyond the structural business mix changes
The webinar is positioned as a focused discussion on the key building blocks of Granules' next phase of growth
